Global Nasal Packing Devices Market Grows Steadily at a CAGR of 5.2%
Temporary or permanent nasal packing is required if the otorhinolaryngologist cannot determine the source of the bleeding and there is no access to specialized equipment or endoscopic management expertise or if the patient cannot tolerate extensive bedside nasal manipulation. Epistaxis is one of the most prevalent clinical diseases that result in bleeding from the nostrils. Consequently, the market is driven by the rising prevalence of hypertension among pregnant women. In addition, the increasing incidence of nasal cancers drives the market.
Epistaxis results from the interaction of several factors that harm the blood vessel walls, the nose's mucosal lining, or reduce the blood's capacity to clot. According to a nosebleed study in the United States, the incidence of nosebleeds is highest among the age of 2 and 10 and elders between the ages of 50 and 80. The increasing prevalence of epistaxis is a significant factor propelling growth in the nasal packing devices market. Nosebleeds are caused by increased blood circulation caused by the circulatory system expansion during pregnancy. As a result, the market's growth is driven by an increase in the number of pregnant women suffering from hypertension.
Crucial elements like niche market penetrations, vendor landscapes, marketing slants, licensing strategies, relative market share, pinpoint analysis, visual analytics, etc., accelerate the market's growth. Leaders in the market are also always looking for cutting-edge technology that could significantly speed up their future commercial growth. The market is propelled forward by an increasing number of product launches and a persistent focus on technological advancements.
Due to the increased use of nasal packing devices to treat an increasing number of epistaxis patients and the rising number of market competitors in the region, North America holds the largest share of the global market for nasal packing devices. The rise in demand for nasal packing devices results from an increase in COVID-19 cases. Asia-Pacific will experience a favorable growth rate in the market during the forecast period.
The global nasal packing devicesmarket’s major key playersare Summit Health; Smith & Nephew; Stryker Corporation; Medtronic plc.; Network medical products ltd.; Lohmann & Rauscher; Meril Life Sciences Pvt Ltd.; FABCO; Aegis Lifesciences, Summit Medical Group, Lohmann & Rauscher GmbH & Co.KG, Olympus Corporation, Entellus Medical, Inc., and Network Medical Products Ltd.